Arbor Pharmaceuticals announced today that the company’s second prescription product, NEOTIC™, has been launched in the U.S. and is now available for the treatment of pain and inflammation associated with middle ear infections (also called Acute Otitis Media, or AOM). Acute otitis media represents the second most common infection among children in the US and the number one reason antibiotics are prescribed by U.S. pediatricians.
The details can be read here.
No comments:
Post a Comment